USPTO serial 90185046
SIREN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMORROW, RONALD G
- Law office
- TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SIREN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Luke Santangelo
LUKE SANTANGELO SANTANGELO LAW OFFICES, P.C.125 SOUTH HOWES ST., 3RD FLOORFORT COLLINS, CO 80521UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of pathogens, infectious diseases, disorders, inflammation, and other conditions; Pharmaceutical preparations and treatments related to the field of virology; Technical consulting; Technical consulting related to, and featuring a technology related to, the field of biotechnology; Technical consulting related to, and featuring a technology related to, the field of nutritional supplements; Technical consulting related to, and featuring a technology related to, the field of probiotics; Technical consulting related to, and featuring a technology related to, the field of pharmaceuticals; Technical consulting related to, and featuring a technology related to, the field of genetic science; Technical consulting related to, and featuring a technology related to, the field of laboratory testing; Technical consulting related to, and featuring a technology related to, the field of pharmacogenetics; Technical consulting related to, and featuring a technology related to, the fields of treatment of conditions in vertebrates, mammals, and humans; Technical consulting related to, and featuring a technology related to, the fields of pathogens, infectious diseases, disorders, inflammation, and other conditions; Technical consulting related to, and featuring a technology related to, the field of virology; Technical consulting related to, and featuring a technology related to, the field of immunology; Consulting services related to, and featuring a technology related to, the field of biotechnology; Consulting services related to, and featuring a technology related to, the field of nutritional supplements; Consulting services related to, and featuring a technology related to, the field of probiotics; Consulting services related to, and featuring a technology related to, the field of pharmaceuticals; Consulting services related to, and featuring a technology related to, the field of genetic science; Consulting services related to, and featuring a technology related to, the field of laboratory testing; Consulting services related to, and featuring a technology related to, the field of pharmacogenetics; Consulting services related to, and featuring a technology related to, the fields of conditions in vertebrates, mammals, and humans; Consulting services related to, and featuring a technology related to, the fields of pathogens, infectious diseases, disorders, inflammation, and other conditions; Consulting services related to, and featuring a technology related to, the field of virology; Consulting services related to, and featuring a technology related to, the field of immunology; Providing medical and scientific research information related to, and featuring a technology related to, the field of biotechnology; Providing medical and scientific research information related to, and featuring a technology related to, the field of nutritional supplements; Providing medical and scientific research information related to, and featuring a technology related to, the field of probiotics; Providing medical and scientific research information related to, and featuring a technology related to, the field of pharmaceuticals; Providing medical and scientific research information related to, and featuring a technology related to, the field of genetic science; Providing medical and scientific research information related to, and featuring a technology related to, the field of laboratory testing; Providing medical and scientific research information related to, and featuring a technology related to, the field of pharmacogenetics; Providing medical and scientific research information related to, and featuring a technology related to, the fields of conditions in vertebrates, mammals, and humans; Providing medical and scientific research information related to, and featuring a technology related to, the fields of pathogens, infectious diseases, disorders, inflammation, and other conditions; Providing medical and scientific research information related to, and featuring a technology related to, virology; Providing medical and scientific research information related to, and featuring a technology related to, immunology; Providing information related to, and featuring a technology related to, the field of biotechnology; Providing information related to, and featuring a technology related to, the field of nutritional supplements; Providing information related to, and featuring a technology related to, the field of probiotics; Providing information related to, and featuring a technology related to, the field of pharmaceuticals; Providing information related to, and featuring a technology related to, the field of genetic science; Providing information related to, and featuring a technology related to, the field of laboratory testing; Providing information related to, and featuring a technology related to, the field of pharmacogenetics; Providing information related to, and featuring a technology related to, the fields of conditions in vertebrates, mammals, and humans; Providing information related to, and featuring a technology related to, the fields of pathogens, infectious diseases, disorders, inflammation, and other conditions; Providing information related to, and featuring a technology related to, the field of virology; Providing information related to, and featuring a technology related to, the field of immunology; Scientific investigation services; Conducting scientific investigations related to, and featuring a technology related to, the field of biotechnology; Conducting scientific investigations related to, and featuring a technology related to, the field of nutritional supplements; Conducting scientific investigations related to, and featuring a technology related to, the field of probiotics; Conducting scientific investigations related to, and featuring a technology related to, the field of pharmaceuticals; Conducting scientific investigations related to, and featuring a technology related to, the field of genetic science; Conducting scientific investigations related to, and featuring a technology related to, the field of laboratory testing; Conducting scientific investigations related to, and featuring a technology related to, the field of pharmacogenetics; Conducting scientific investigations related to, and featuring a technology related to, the fields of conditions in vertebrates, mammals, and humans; Conducting scientific investigations related to, and featuring a technology related to, the fields of pathogens, infectious diseases, disorders, inflammation, and other conditions; Conducting scientific investigations related to, and featuring a technology related to, the field of virology; Conducting scientific investigations related to, and featuring a technology related to, the field of immunology; Providing technical information related to, and featuring a technology related to, the field of biotechnology; Providing technical information related to, and featuring a technology related to, the field of nutritional supplements; Providing technical information related to, and featuring a technology related to, the field of probiotics; Providing technical information related to, and featuring a technology related to, the field of pharmaceuticals; Providing technical information related to, and featuring a technology related to, the field of genetic science; Providing technical information related to, and featuring a technology related to, the field of laboratory testing; Providing technical information related to, and featuring a technology related to, the field of pharmacogenetics; Providing technical information related to, and featuring a technology related to, the fields of conditions in vertebrates, mammals, and humans; Providing technical information related to, and featuring a technology related to, the fields of pathogens, infectious diseases, disorders, inflammation, and other conditions; Providing technical information related to, and featuring a technology related to, the field of virology; Providing technical information related to, and featuring a technology related to, the field of immunology; Educational services related to, and featuring a technology related to, the field of biotechnology; Educational services related to, and featuring a technology related to, the field of nutritional supplements; Educational services related to, and featuring a technology related to, the field of probiotics; Educational services related to, and featuring a technology related to, the field of pharmaceuticals; Educational services related to, and featuring a technology related to, the field of genetic science; Educational services related to, and featuring a technology related to, the field of laboratory testing; Educational services related to, and featuring a technology related to, the field of pharmacogenetics; Educational services related to, and featuring a technology related to, the fields of conditions in vertebrates, mammals, and humans; Educational services related to, and featuring a technology related to, the fields of pathogens, infectious diseases, disorders, inflammation, and other conditions; Educational services related to, and featuring a technology related to, the field of virology; Educational services related to, and featuring a technology related to, the field of immunology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 16, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 16, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 30, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |